EQL Pharma as an Investment
EQL Pharma´s share is listed on Nasdaq Stockholm Main Market since 2024. Some reasons that make EQL Pharma’s share an interesting investment:
- The focus on niche generics provides a competitive advantage as the large pharmaceutical companies have a different focus.
- Low costs for marketing as medicines in the Nordics are sold according to the pharmacies exchange system.
- Collaboration with the Indian pharmaceutical company Cadila Pharmaceuticals.
- Target to grow 40% in turnover per financial year.
- Great opportunities for expansion in markets outside the Nordics.